Carl Kraus
Technik-/Wissenschafts-/F&E-Leiter bei AQUESTIVE THERAPEUTICS, INC.
Vermögen: 1 Mio $ am 30.04.2024
Profil
Carl N.
Kraus was the founder of Arrevus, Inc. founded in 2015, where he held the titles of Chairman, President & Chief Executive Officer from 2017 to 2021.
Currently, he is the Medical Director at i3 Research, Inc. and the Chief Medical Officer at Aquestive Therapeutics, Inc. since 2023.
Previously, he served as the Chief Medical Officer at Idera Pharmaceuticals, Inc. and Resilience Government Services, Inc. He was also the Chief Medical Officer at Aceragen, Inc. from 2021 to 2023.
Dr. Kraus received his undergraduate degree from Washington University School of Medicine.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
07.03.2024 | 262 500 ( 0,29% ) | 1 Mio $ | 30.04.2024 | |
ACERAGEN, INC.
-.--% | 17.01.2023 | 0 ( -.--% ) | - $ | 31.07.2023 |
Aktive Positionen von Carl Kraus
Unternehmen | Position | Beginn |
---|---|---|
AQUESTIVE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 26.06.2023 |
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Carl Kraus
Unternehmen | Position | Ende |
---|---|---|
ACERAGEN, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2023 |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Vorstandsvorsitzender | 31.10.2021 |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Carl Kraus
Washington University School of Medicine | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ACERAGEN, INC. | Health Technology |
AQUESTIVE THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
i3 Research, Inc.
i3 Research, Inc. Miscellaneous Commercial ServicesCommercial Services i3 Research, Inc. undertakes medical research services. The company focuses on central nervous system, oncology, respiratory and infectious diseases, endocrinology and metabolic diseases, and cardiology. It offers clinical research solutions, including project management, investigator recruitment, patient recruitment, and regulatory services. The company is located in Basking Ridge, NJ. | Commercial Services |
Resilience Government Services, Inc.
Resilience Government Services, Inc. Pharmaceuticals: MajorHealth Technology Resilience Government Services, Inc. engages in the development of biopharmaceutical products and medical devices. It also offers preclinical and clinical development, formulation optimization, and cGMP manufacturing. The company was founded by James D. Talton in 1999 and is headquartered in Alachua FL. | Health Technology |
Arrevus, Inc.
Arrevus, Inc. BiotechnologyHealth Technology Arrevus, Inc. develops designer proline-rich antimicrobial peptide chaperone-protein inhibitors to treat diseases for which antibiotic resistance has clinical implications. The company was founded by Carl N. Kraus in 2015 and is headquartered in Raleigh, NC. | Health Technology |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |